TR2021021367A1 - SKIN PRODUCT CONTAINING ROSE CHAMOMILE EXTRACT - Google Patents
SKIN PRODUCT CONTAINING ROSE CHAMOMILE EXTRACTInfo
- Publication number
- TR2021021367A1 TR2021021367A1 TR2021/021367 TR2021021367A1 TR 2021021367 A1 TR2021021367 A1 TR 2021021367A1 TR 2021/021367 TR2021/021367 TR 2021/021367 TR 2021021367 A1 TR2021021367 A1 TR 2021021367A1
- Authority
- TR
- Turkey
- Prior art keywords
- skin
- rose
- plant
- essence
- skin product
- Prior art date
Links
- 241000220317 Rosa Species 0.000 title claims abstract description 29
- 229940119217 chamomile extract Drugs 0.000 title description 5
- 235000020221 chamomile extract Nutrition 0.000 title description 5
- 239000000284 extract Substances 0.000 claims abstract description 12
- 244000000010 microbial pathogen Species 0.000 claims abstract description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 10
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 9
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 7
- 230000036559 skin health Effects 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 3
- 239000000341 volatile oil Substances 0.000 claims abstract description 3
- 241000404028 Anthemis Species 0.000 claims description 2
- 239000002537 cosmetic Substances 0.000 claims description 2
- 238000004821 distillation Methods 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims description 2
- 238000000605 extraction Methods 0.000 claims description 2
- 239000000346 nonvolatile oil Substances 0.000 claims description 2
- 239000004094 surface-active agent Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 8
- 230000000845 anti-microbial effect Effects 0.000 abstract description 7
- 230000003078 antioxidant effect Effects 0.000 abstract description 4
- 241001674934 Anthemis rosea subsp. carnea Species 0.000 abstract description 3
- 210000003491 skin Anatomy 0.000 description 62
- 239000003755 preservative agent Substances 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000001965 increasing effect Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 230000003833 cell viability Effects 0.000 description 3
- 230000008439 repair process Effects 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- 102000008186 Collagen Human genes 0.000 description 2
- 108010035532 Collagen Proteins 0.000 description 2
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 244000228451 Stevia rebaudiana Species 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 235000011399 aloe vera Nutrition 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 229940024606 amino acid Drugs 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 229920001436 collagen Polymers 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 235000018102 proteins Nutrition 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 150000008163 sugars Chemical class 0.000 description 2
- 229940045136 urea Drugs 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- AEQDJSLRWYMAQI-UHFFFAOYSA-N 2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline Chemical compound C1CN2CC(C(=C(OC)C=C3)OC)=C3CC2C2=C1C=C(OC)C(OC)=C2 AEQDJSLRWYMAQI-UHFFFAOYSA-N 0.000 description 1
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 235000019489 Almond oil Nutrition 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 244000144927 Aloe barbadensis Species 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- 244000260524 Chrysanthemum balsamita Species 0.000 description 1
- 235000005633 Chrysanthemum balsamita Nutrition 0.000 description 1
- KRKNYBCHXYNGOX-UHFFFAOYSA-K Citrate Chemical compound [O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O KRKNYBCHXYNGOX-UHFFFAOYSA-K 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 208000002197 Ehlers-Danlos syndrome Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 1
- OQILCOQZDHPEAZ-UHFFFAOYSA-N Palmitinsaeure-octylester Natural products CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 235000006092 Stevia rebaudiana Nutrition 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 239000008168 almond oil Substances 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- 229940064062 alpha-glucan oligosaccharide Drugs 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 229960000510 ammonia Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 229960003121 arginine Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 229960005261 aspartic acid Drugs 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 150000001735 carboxylic acids Chemical class 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- KVEAILYLMGOETO-UHFFFAOYSA-H dicalcium magnesium diphosphate Chemical compound P(=O)([O-])([O-])[O-].[Mg+2].[Ca+2].[Ca+2].P(=O)([O-])([O-])[O-] KVEAILYLMGOETO-UHFFFAOYSA-H 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- -1 dimethicone Chemical compound 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N dodecahydrosqualene Natural products CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 1
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- GJQLBGWSDGMZKM-UHFFFAOYSA-N ethylhexyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(CC)CCCCC GJQLBGWSDGMZKM-UHFFFAOYSA-N 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000005923 long-lasting effect Effects 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229940042472 mineral oil Drugs 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 229940056211 paraffin Drugs 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920001296 polysiloxane Polymers 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229940094944 saccharide isomerate Drugs 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 244000005714 skin microbiome Species 0.000 description 1
- 239000000176 sodium gluconate Substances 0.000 description 1
- 235000012207 sodium gluconate Nutrition 0.000 description 1
- 229940005574 sodium gluconate Drugs 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 239000001540 sodium lactate Substances 0.000 description 1
- 229940005581 sodium lactate Drugs 0.000 description 1
- 235000011088 sodium lactate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- CRPCXAMJWCDHFM-UHFFFAOYSA-M sodium;5-oxopyrrolidine-2-carboxylate Chemical compound [Na+].[O-]C(=O)C1CCC(=O)N1 CRPCXAMJWCDHFM-UHFFFAOYSA-M 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- LADGBHLMCUINGV-UHFFFAOYSA-N tricaprin Chemical compound CCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCC)COC(=O)CCCCCCCCC LADGBHLMCUINGV-UHFFFAOYSA-N 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 239000012178 vegetable wax Substances 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Abstract
Buluşun konusu, içerisine ilave edildiği cilt ürününde patojenik mikroorganizma oluşumunu engelleyen, doğal olması sayesinde cilt sağlığını bozmayan gül papatya bitkisinin (Anthemis rosea subsp. carnea) özünü içeren bir cilt ürünü ile ilgilidir. Gül papatya bitkisinin özü olarak bitkinin kapitulumlarından elde edilen ekstre, su (hidrola), uçucu yağ veya bunların karışımları kullanılabilmektedir. Gül papatya bitkisinin özü doğal olması ve antimikrobiyal özelliğe sahip olmasının yanı sıra sahip olduğu antioksidan özelliği sayesinde hücre canlılığını arttırmakta, cilt bakımı sağlamaktadır. Cilt ürünü birden fazla etkiye sahip bu özü içermesi sayesinde tek ajanla ve tek başına cilde birden fazla fayda sağlamaktadır.The subject of the invention relates to a skin product containing the essence of the rose daisy plant (Anthemis rosea subsp. carnea), which prevents the formation of pathogenic microorganisms in the skin product to which it is added and does not harm skin health thanks to its natural nature. As the essence of the rose daisy plant, extract obtained from the capitula of the plant, water (hydrola), essential oil or their mixtures can be used. In addition to the fact that the essence of the rose daisy plant is natural and has antimicrobial properties, it increases cell vitality and provides skin care thanks to its antioxidant properties. Thanks to the skin product containing this essence, which has multiple effects, it provides multiple benefits to the skin with and without a single agent.
Description
TARIFNAME GÜL PAPATYA özÜ IÇEREN CILT ÜRÜNÜ Bulusun Konusu Bulusun konusu, içerisine ilave edildigi cilt ürününde patojenik mikroorganizma olusumunu engelleyen, dogal olmasi sayesinde cilt sagligini bozmayan gül papatya bitkisinin (Anthemi's rosea subsp. carnea (Boiss.) Grierson) özünü içeren bir cilt ürünü ile Teknigin Bilinen Durumu Cilt vücudun, iç organlari dis çevreden ayirarak, mekanik, kimyasal ve biyolojik dis etkilere karsi koruyan, atmosferden agirliklarinin 3-4 kati su çekerek cildin su dengesinin düzenlenmesini, cildin elastik yapisinin ve dogal florasinin korunmasini saglayan serbest amino asitler, karboksilik asit, sekerler, üre, amonyak, ürik asit, keratin, kalsiyum, magnezyum, fosfat, sitrat, klorür gibi dogal nemlendirici faktörleri içeren, kolajen ve protein üretimi yaparak kendini onarabilen önemli bir bölümüdür. Cildin dogal yapisi gün içinde patojenik mikroorganizmalarin biriktigi birçok yüzeyle, hava ve su ile sürekli temas etmesi sebebiyle bozulabilmektedir. Patojenik mikroorganizmalarin etkisiz hale getirilmesi için cilde uygulanan dezenfektanlar ve/veya kuru hava ciltteki dogal nemlendirici faktörlerin azalmasina, dolayisiyla cildin su içeriginin de azalmasina, ciltte nemlendirici etkiye sahip Iipitlerin üretiminin de azalmasina sebep olmaktadir. Su kaybi cildi kurutmakta, kuruyan ciltte kasinti, soyulmalar ve çatlaklar meydana gelmektedir. Cildin nem dengesinin bozulmasi ile cilt florasinda bulunan faydali mikroorganizmalarin sayilari azalmakta, flora dengesi bozulmakta, ciltte enfeksiyonlar meydana gelmektedir. Cildin dogal yapisinin korunmasi amaciyla nemlendirici, yatistirici, onarici, Sikilastirici ve benzeri özelliklerden en az birine sahip cilt ürünleri kullanilmaktadir. Bu ürünler, içerisinde küf, maya, bakteri gibi ürün etkinligini bozacak patojenik mikroorganizmalarin üremesinin engellenmesi amaciyla antimikrobiyal koruyucular içermektelerdir. Mevcut durumda kullanilan cilt ürünleri sentetik ve/veya yari sentetik koruyucular içermektelerdir. Bu tür koruyucularin hücre canliligini azaltici ve karsinojenik etkileri bulunmaktadir. Dolayisiyla cilt ürünleri özellikle hassas ve savunmasiz ciltlere uygulanmalari durumunda cildi desteklemeleri, onarmalari, güçlendirmeleri beklenirken bu koruyuculari içerdikleri için aksine cilt hücrelerinin kaybina, cildin dogal florasinin ve nem dengesinin, yani yapisinin bozulmasina yol açmaktalardir. Ayrica konvansiyonel cilt ürünleri cildi nemlendirme, hücre canliligini arttirarak onarma, sikilastirma gibi etkilere de sahip olabilmesi için antimikrobiyal koruyuculara ilave olarak her etki için ayri bir dogal veya sentetik veya yari sentetik cilt bakim ajani içermektedir. Bu durum da üretim maliyetlerini ve ürün maliyetlerini arttirmaktadir. Bu sebeple cilt bakim ürünlerinde patojenik mikroorganizma olusumunu engelleyen ancak cilt sagligini bozmayan, hatta cildi sahip oldugu birden fazla etki ile güçlendiren dogal ajan içeren cilt ürünlerine ihtiyaç duyulmaktadir. Bahsedilen ihtiyacin karsilanmasi amaciyla bulus kapsaminda antimikrobiyal özelligi sayesinde üründe patojenik mikroorganizma olusumunu engelleyen, dolayisiyla ürünün uzun süre etkili olmasini saglayan, cilde zarar vermeyen, hatta antimikrobiyal özelliginin yani sira sahip oldugu antioksidan/hücre canliligi arttirici/onarici özellikleri sayesinde cildi güçlendiren, ülkemizin Akdeniz Bölgesi'nin endemik bitkisi olan gül papatya bitkisinin (Anthemis rosea subsp. carnea) özünü içeren cilt ürünü gelistirilmistir. Birden fazla etkiye, içerdigi tek ajan sayesinde sahip olan bir ürün elde edilebilmekte ve tek ürün kullanimiyla bahsedilen etkilerin her birinin faydasi cilde ayni anda saglanabilmektedir. Bitki özünün dogal hos kokusu sayesinde esans kullanilmasina da gerek kalmamaktadir. Dolayisiyla gül papatya özünü içeren cilt ürünlerinin üretimi ve kullanimi, konvansiyonel cilt ürünlerine kiyasla üreticiler ve tüketiciler için daha ekonomik olmaktadir. Bulusun Amaci Bulusun amaci, sentetik veya yari sentetik koruyucular içermeyen, patojenik mikroorganizma olusumunu engellerken cilt sagligini bozmayan dogal gül papatya özünü içeren cilt ve çevre dostu bir cilt ürünü gelistirmektir. Bulusun baska bir amaci, antimikrobiyal etkinin yani sira antioksidan/hücre canliligini arttirici/onarici etkilerin tümünün tek bilesenle saglandigi bir cilt ürünü gelistirmektir. Bulusun baska bir amaci, cilde birden fazla faydayi tek basina saglayan, dolayisiyla tüketiciler için birden fazla ürün kullanimi mecburiyetini ortadan kaldiran, ekonomik bir cilt ürünü gelistirmektir. Bulusun baska bir amaci, antimikrobiyal, antioksidan özellikleri ile hücre canliligini arttirma, cildi güçlendirme etkilerine sahip dogal gül papatya bitkisinin cilt ürünlerinde kullanilmasini saglamak, gül papatya bitkisine yeni bir kullanim alani kazandirmaktir. Bulusun Açiklamasi Bulusun konusu, içerisine ilave edildigi cilt ürününde patojenik mikroorganizma olusumunu engelleyen, dogal olmasi sayesinde cilt sagligini da bozmayan gül papatya bitkisinin (Anthemis rosea subsp. carnea) özünü içeren bir cilt ürünü ile ilgilidir. Bulus konusu cilt ürünü gül papatya bitkisinin özü olarak bitkinin çiçeklerinin kapitulumlarinin ekstresini, suyunu (hidrolasi), uçucu yagini veya bunlarin karisimlarini içerebilmektedir. Gül papatya bitkisinin özü tercihen distilasyon ve/veya ekstraksiyon metotlari kullanilarak elde edilebilmektedir. Bulus konusu cilt ürünü gül papatya bitkisinin özünü tercihen agirlikça % 0,01-3 oraninda içermektedir. Yapilan klinik çalismalarda gül papatya özünü belirtilen oranlarda içeren cilt ürününün koruyucu içermeyen veya sentetik ve/veya yari sentetik koruyucu içeren referans ürünlerin aksine hücre canliligini azaltmadigi, hatta uygulama öncesine göre hücre canliligini arttirdigi sonucuna varilmistir. Bulus konusu cilt ürünü gül papatya bitkisinin özünü tercihen agirlikça % 0,1-2 oraninda içermektedir. Bulus konusu cilt ürünü tercih edilen bazi uygulamalarinda gül papatya bitkisinin özüne ilave olarak en az bir tür sabit yag içerebilmektedir. Bulus konusu cilt ürünü tercih edilen bazi uygulamalarinda gül papatya bitkisinin özüne ilave olarak en az bir emülgatör içerebilmektedir. Bulus konusu cilt ürünü tercih edilen bazi uygulamalarinda gül papatya bitkisinin özüne ilave olarak en az bir yüzey aktif madde içerebilmektedir. Bulus konusu cilt ürünü tercih edilen bazi uygulamalarinda gül papatya bitkisinin özüne ilave olarak en az bir cilt bakim ajani içerebilmektedir. Bahsedilen uygulamalarda cilt bakim ajani/ajanlari bu alternatiflerle sinirli olmamak üzere cildi nemlendiren ve/veya onaran ve/veya sikilastiran ve/veya cildin florasini düzenleyen ajanlar arasindan, tercihen gliserin, propilen glikol, pentilen glikol, kaprilil glikol gibi polihidrik alkoller veya retinol (a vitamini), riboflavin (BZ vitamini), niyasinamid (B3 vitamini), pantenol (provitamin B5), biyotin, folik asit, tokoferil asetat (E vitamini) gibi vitaminler veya bisabolol, allantoin, lanolin, üre, sodyum hyaluronat, peg-75 lanolin, sodyum laktat, sodyum glukonat, sodyum pca, zeytinyagi peg-7 esteri, sakkarit izomerat, seker otu (Stevia rebaudiana) ekstresi, hindistan cevizi (Cocos nucifera) meyve ekstresi, tibbi sarisabir (Aloe barbadensis leaf) ekstresi gibi ekstreler veya fruktoz, maltoz, glukoz, sorbitol, maltodekstrin, trehaloz, Iaktoz gibi sekerler veya kolajen, keratin, süt proteini gibi proteinler, bifida ferment Iizat, alfa-glukan oligosakkarit, lactobaci'i'lus, inulin gibi probiyotik-prebiyotik katkilar veya arjinin, aspartik asit, glisin, alanin, serin, valin, prolin, treonin, Izolösin, histidin, fenilalanin gibi cildin dogal yapisinda bulunan aminoasitler veya etilheksil palmitat, izopropil miristat, izopropil palmitat, kaprilik/kaprik trigliserit, koko kaprilat/kaprat gibi cilt yumusaticilari veya dimetikon gibi silikonlar, jojoba yagi, badem yagi, avakado yagi gibi bitkisel yaglar veya vazelin, skualen, parafin, mineral yag gibi hidrokarbon yaglar veya yag asitleri veya yag alkolleri veya esterler veya peptitler veya bitkisel mumlar veya fosfolipidler veya steroller arasindan seçilebilmektedir. Bulus konusu cilt ürünü tercih edilen bazi uygulamalarinda gül papatya bitkisinin özüne ilave olarak su içerebilmektedir. Bulus konusu cilt ürünü tercihen kozmetik bir üründür. Açiklanan cilt ürününde içerdigi dogal bilesen sayesinde patojenik mikroorganizma olusmamakta, dolayisiyla ürün uzun süre etki göstermekte, cilt sagligi bozulmamakta, hatta cildin tahris olmasi engellenmekte, hücre canliligi arttirilarak cilt onarilmakta ve güçlendirilmektedir. Konvansiyonel cilt ürünlerinde, tüm bu islevler birden fazla ajanla saglanirken, bulus konusu üründe yalnizca gül papatya bitkisinin özü ile saglanmaktadir. Bu sayede gül papatya bitkisinin özünü içeren cilt ürünlerinin üretimi ve kullanimi, konvansiyonel cilt ürünlerine kiyasla üreticiler ve tüketiciler için daha ekonomik olmaktadir. TR TR DESCRIPTION SKIN PRODUCT CONTAINING ROSE CHAMOMILE EXTRACT Subject of the Invention The subject of the invention is a skin product containing the essence of the rose daisy plant (Anthemi's rosea subsp. carnea (Boiss.) Grierson), which prevents the formation of pathogenic microorganisms in the skin product to which it is added and does not harm skin health thanks to its natural nature. Known Status: The skin protects the body against mechanical, chemical and biological external effects by separating the internal organs from the external environment, draws 3-4 times their weight of water from the atmosphere, regulates the skin's water balance, and protects the skin's elastic structure and natural flora. Free amino acids, carboxylic acids, sugars. It is an important part of the body that contains natural moisturizing factors such as urea, ammonia, uric acid, keratin, calcium, magnesium, phosphate, citrate and chloride, and can repair itself by producing collagen and protein. The natural structure of the skin can be damaged due to constant contact with many surfaces, air and water where pathogenic microorganisms accumulate during the day. Disinfectants applied to the skin to neutralize pathogenic microorganisms and/or dry air cause the natural moisturizing factors in the skin to decrease, therefore the water content of the skin decreases, and the production of lipids that have a moisturizing effect on the skin decreases. Water loss dries the skin, causing itching, peeling and cracks on the dried skin. When the moisture balance of the skin is disrupted, the number of beneficial microorganisms in the skin flora decreases, the flora balance is disrupted, and infections occur on the skin. In order to protect the natural structure of the skin, skin products that have at least one of the features such as moisturizing, soothing, repairing, firming and similar are used. These products contain antimicrobial preservatives to prevent the growth of pathogenic microorganisms such as mold, yeast and bacteria that will impair product effectiveness. Currently used skin products contain synthetic and/or semi-synthetic preservatives. Such preservatives have decreasing cell viability and carcinogenic effects. Therefore, while skin products are expected to support, repair and strengthen the skin, especially when applied to sensitive and vulnerable skin, since they contain these preservatives, on the contrary, they cause the loss of skin cells and the deterioration of the skin's natural flora and moisture balance, that is, its structure. In addition, conventional skin products contain a separate natural or synthetic or semi-synthetic skin care agent for each effect, in addition to antimicrobial preservatives, in order to have effects such as moisturizing the skin, repairing it by increasing cell vitality, and tightening it. This situation increases production costs and product costs. For this reason, there is a need for skin care products that contain natural agents that prevent the formation of pathogenic microorganisms but do not harm skin health, and even strengthen the skin with multiple effects. In order to meet the mentioned need, within the scope of the invention, thanks to its antimicrobial properties, it prevents the formation of pathogenic microorganisms in the product, therefore ensures the product to be effective for a long time, does not harm the skin, and even strengthens the skin thanks to its antioxidant / cell vitality increasing / repairing properties, in addition to its antimicrobial properties, in the Mediterranean Region of our country. A skin product containing the extract of the rose daisy plant (Anthemis rosea subsp. carnea), which is the endemic plant of Turkey, has been developed. A product that has more than one effect can be obtained thanks to the single agent it contains, and with the use of a single product, the benefits of each of the mentioned effects can be provided to the skin at the same time. Thanks to the natural pleasant smell of the plant essence, there is no need to use essence. Therefore, the production and use of skin products containing rose chamomile extract is more economical for manufacturers and consumers compared to conventional skin products. Purpose of the Invention The purpose of the invention is to develop a skin and environmentally friendly skin product containing natural rose chamomile extract, which does not contain synthetic or semi-synthetic preservatives and does not harm skin health while preventing the formation of pathogenic microorganisms. Another aim of the invention is to develop a skin product in which all antimicrobial effects as well as antioxidant/cell vitality enhancing/repairing effects are provided with a single component. Another purpose of the invention is to develop an economical skin product that provides multiple benefits to the skin on its own, thus eliminating the need for consumers to use more than one product. Another purpose of the invention is to enable the use of the natural rose daisy plant, which has antimicrobial and antioxidant properties, increasing cell vitality and strengthening the skin, in skin products, and to provide a new area of use for the rose daisy plant. Description of the Invention The subject of the invention is about a skin product containing the essence of the rose daisy plant (Anthemis rosea subsp. carnea), which prevents the formation of pathogenic microorganisms in the skin product to which it is added and does not harm skin health thanks to its natural nature. The skin product of the present invention may contain the extract of the rose daisy plant, the extract of the capitulum of the flowers of the plant, its water (hydrolase), its essential oil or mixtures of these. The extract of the rose daisy plant can preferably be obtained using distillation and/or extraction methods. The skin product of the invention preferably contains the essence of the rose chamomile plant at a rate of 0.01-3% by weight. Clinical studies have concluded that the skin product containing rose chamomile extract in the specified proportions does not reduce cell viability, unlike reference products that do not contain preservatives or contain synthetic and/or semi-synthetic preservatives, and even increases cell viability compared to before application. The skin product of the invention preferably contains the essence of the rose chamomile plant at a rate of 0.1-2% by weight. In some preferred applications, the skin product of the invention may contain at least one type of fixed oil in addition to the essence of the rose chamomile plant. In some preferred applications, the skin product of the invention may contain at least one emulsifier in addition to the essence of the rose chamomile plant. In some preferred applications, the skin product of the invention may contain at least one surfactant in addition to the essence of the rose chamomile plant. In some preferred applications, the skin product of the invention may contain at least one skin care agent in addition to the essence of the rose chamomile plant. In the mentioned applications, the skin care agent(s) are among the agents that moisturize and/or repair and/or firm the skin and/or regulate the skin's flora, including but not limited to these alternatives, preferably polyhydric alcohols such as glycerin, propylene glycol, pentylene glycol, caprylyl glycol or retinol (vitamin A). ), riboflavin (vitamin BZ), niacinamide (vitamin B3), panthenol (provitamin B5), biotin, folic acid, tocopheryl acetate (vitamin E) or bisabolol, allantoin, lanolin, urea, sodium hyaluronate, peg-75 lanolin, extracts such as sodium lactate, sodium gluconate, sodium PCA, olive oil peg-7 ester, saccharide isomerate, stevia (Stevia rebaudiana) extract, coconut (Cocos nucifera) fruit extract, medicinal aloe (Aloe barbadensis leaf) extract or fructose, maltose, Sugars such as glucose, sorbitol, maltodextrin, trehalose, lactose or proteins such as collagen, keratin, milk protein, probiotic-prebiotic additives such as bifida ferment Iizat, alpha-glucan oligosaccharide, lactobaci'i'lus, inulin or arginine, aspartic acid, glycine, Amino acids found in the natural structure of the skin such as alanine, serine, valine, proline, threonine, isoleucine, histidine, phenylalanine or skin softeners such as ethylhexyl palmitate, isopropyl myristate, isopropyl palmitate, caprylic/capric triglyceride, coco caprylate/caprate or silicones such as dimethicone, jojoba oil. , almond oil, avocado oil, or hydrocarbon oils such as vaseline, squalene, paraffin, mineral oil, or fatty acids, or fatty alcohols, or esters, or peptides, or vegetable waxes, or phospholipids, or sterols. In some preferred applications, the skin product of the invention may contain water in addition to the essence of the rose and daisy plant. The skin product of the invention is preferably a cosmetic product. Thanks to the natural ingredient it contains in the described skin product, no pathogenic microorganisms are formed, therefore the product has a long-lasting effect, skin health is not impaired, even skin irritation is prevented, and the skin is repaired and strengthened by increasing cell vitality. While all these functions are provided by more than one agent in conventional skin products, in the product of the invention they are provided only with the extract of the rose chamomile plant. In this way, the production and use of skin products containing the essence of the rose chamomile plant is more economical for manufacturers and consumers compared to conventional skin products. TR TR
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/TR2022/050726 WO2023128963A1 (en) | 2021-12-28 | 2022-07-07 | Skin product comprising anthemis rosea subsp. carnea (boiss.) grierson extract |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR2021021367A1 true TR2021021367A1 (en) | 2023-07-21 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10004681B2 (en) | Seaweed-derived cosmetic compositions | |
| US9833642B2 (en) | Skin care formulations | |
| JP5798745B2 (en) | Topically applied cosmetic or pharmaceutical composition | |
| JP7209672B2 (en) | Cosmetics and methods for producing cosmetics | |
| WO2014103475A1 (en) | Skin-exterior anti-ageing composition and production method therefor | |
| JP5063842B2 (en) | Hyaluronidase activity inhibitor and moisturizing cosmetic | |
| CA2701378C (en) | Seaweed-derived cosmetic compositions | |
| CN110731974B (en) | Skin external composition with enhanced anti-inflammatory efficacy | |
| JP2005306831A (en) | Skin care preparation for external use | |
| KR101909980B1 (en) | Cosmetic composition containing moisturizing complex | |
| JP2004323401A (en) | Skin care preparation for external use | |
| JP5241054B2 (en) | Composition for promoting collagen synthesis | |
| KR20180118409A (en) | Nutrition Cream Containing Ergothioneine and Its Manufacturing Method | |
| KR20160129453A (en) | Cosmetic composition for skin winkle improvement containing Fermented extract of horse placenta and horse oil | |
| US20110086115A1 (en) | Vegetal-Derived, Water-Absorbing Composition | |
| JP6999267B2 (en) | Lupine peptide extract and skin tension | |
| KR101151008B1 (en) | Cosmetic composition containing phytantriol and hexamidine diisethionate for improving acnes | |
| TR2021021367A1 (en) | SKIN PRODUCT CONTAINING ROSE CHAMOMILE EXTRACT | |
| TR2021021373A1 (en) | SKIN PRODUCT CONTAINING SPARK TEA EXTRACT | |
| WO2023128963A1 (en) | Skin product comprising anthemis rosea subsp. carnea (boiss.) grierson extract | |
| JP2019196338A (en) | Moisturizer | |
| KR20200071334A (en) | composition comprising extract of ribes nigrum fruit and grape fruit for improving skin wrinkle and elasticity, cosmetic composition using the same and cosmetic using the same | |
| JP5520703B2 (en) | Composition for promoting collagen synthesis | |
| WO2023128949A1 (en) | Skin care product comprising halloysite nanotubes | |
| WO2022119532A1 (en) | Alcohol-based product enabling to disinfect the skin and supporting the skin flora |